Article Sidebar
Views pdf: 43
ROLE OF THE REDUCTION GASTRECTOMY FOR UNRESECTABLE GASTRIC CANCER
Main Article Content
Abstract
Background: Role of reduction gastrectomy in the treatment of stage IV gastric cancer remains unclear. This study aims to evaluate the short- and long-term oncologic outcomes of reduction gastrectomy for un resectable gastric cancer. Method: This was a retrospective cohort study including 132 patients with stage IV gastric cancer patients who underwent reduction gastrectomy from Jan 2013 to Jun 2020 at the Department of Gastro-Intestinal Surgery, University Medical Center at Ho Chi Minh City. Results: The mean age was 59.5 years. The rate of overall postoperative complication was 21.2%, and the rate of severe complications was 5.3%. The overall survival time was 21,3 ± 9,6 months. The one-, three-, and five-year overall survival rates were 49%, 11%, and 6%, respectively. Differentiation, lymph nodes metastasis, and adjuvant chemotherapy were identified as independent risk factors associated with overall survival. Conclusion: Reduction gastrectomy was safe for the treatment of stage IV gastric cancer.
Article Details
Keywords
reduction gastrectomy; gastric cancer; overall survival
References
2. Jingxu S, Yongxi S et al (2013). Clinical significance of palliative gastrectomy on the survival of patient with incurable advanced gastric cancer: a system review and meta-analysis. BMC Cancer 2013, 13, pp. 577.
3. Kobayashi A, Nakagohri T et al (2004). Aggressive surgical treatment for T4 gastric cancer. J Gastrointest Surg, 8(4), pp. 464-470.
4. Ruy K W, Kim Y W, Lee J H, Nam B H (2008). Surgical complications and the risk factors of laparoscopy – assisted distal gastrectomy for advanced gastric cancer. Ann Surg Oncol, 15, pp. 1625-1631.
5. Zhong Zhang J, Shan Lu H et al (2011), “Outcome of palliative total gastrectomy for stage IV proximal gastric cancer”, Am J Surg, 202(1), pp. 91-96.
6. Yang K, Liu K et al (2015), “The value of palliative gastrectomy for gastric cancer patients with intraoperatively proven peritoneal seeding”. Medicine, 94(27), pp. 1-9.
7. Ozer I, Birol Bostanci E et al (2009), “Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer ”, Am J Surg, 198(1), pp. 25-30.
8. Fujitani K, Kwang Yang H et al (2016), “Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non- curable factor (REGATTA): a phase 3, randomized controlled trial”, The Lancet Oncology, s1470-2045 (15), pp. 1-10.